ProSomnus, Inc. Common Stock
OSA
$-0.04
Change (1 day)
$5.25
Year High
$0.35
Year Low
Categories
Prosomnus Sleep Technologies, Inc. designs, manufactures, and markets sleep apnea therapy devices for dentists to treat patients diagnosed with obstructive sleep apnea. The company was incorporated in 2016 and is based in Pleasanton, California.
Revenue of ProSomnus, Inc. Common Stock (OSA)
Revenue in 2023 (TTM): $27.65 M
According to ProSomnus, Inc. Common Stock's latest financial reports the company's current revenue (TTM) is $27.65 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of ProSomnus, Inc. Common Stock
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $27.65 M | $14.01 M | $-17,735,000 | $-24,095,000 | $-24,095,000 |
| 2022 | $19.39 M | $10.27 M | $-11,475,493 | $-7,145,320 | $3.3 M |
| 2021 | $14.07 M | $7.31 M | $-3,987,318 | $-5,969,755 | $-5,977,407 |
| 2020 | $8.29 M | $4.12 M | $-3,574,718 | $-6,155,350 | $-6,173,015 |